Differentiating drugs by harm potential: the rational versus the feasible
Related Experiment Video
Updated: Oct 24, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
1Department of Pharmacology, University of Toronto, Ontario, Canada.
Abstract:
In an ideal harm reduction model, drugs would be ranked according to their potential to cause harm, with varying implications for control policies and interventions. In such a public health oriented approach, the maximum protection of the public from harm would be balanced with the least possible restriction of freedom. In reality, however, the accuracy and completeness of the necessary information for such a ranking is highly limited. Many other factors not readily incorporated in a rational model, such as values, beliefs, and traditions, also affect drug policy decisions. Thus, rather than relying on acquisition of the necessary knowledge, it may be preferable to focus efforts on developing effective nonlegal measures to reduce drug use and harm. [Translations are provided in the International Abstracts Section of this issue.]
Related Concept Videos
Dose-Response Relationship: Potency and Efficacy
Dosage Regimen: Individualization
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmaceutical Poisoning: Potential Scenarios
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...